Group One Trading’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-16,288
| Closed | -$243K | – | 5639 |
|
|
2018
Q4 | $247K | Buy |
+16,288
| New | +$310K | ﹤0.01% | 2522 |
|
|
2018
Q1 | – | Sell |
-8,634
| Closed | -$146K | – | 5537 |
|
|
2017
Q4 | $114K | Sell |
8,634
-1,692
| -16% | -$25.5K | ﹤0.01% | 3285 |
|
|
2017
Q3 | $191K | Sell |
10,326
-15,519
| -60% | -$289K | ﹤0.01% | 2794 |
|
|
2017
Q2 | $476K | Sell |
25,845
-13,812
| -35% | -$274K | ﹤0.01% | 2002 |
|
|
2017
Q1 | $894K | Buy |
39,657
+37,813
| +2,051% | +$905K | 0.01% | 1413 |
|
|
2016
Q4 | $64K | Buy |
+1,844
| New | +$55.1K | ﹤0.01% | 3111 |
|
|
2016
Q3 | – | Sell |
-1,510
| Closed | -$37.7K | – | 5083 |
|
|
2016
Q2 | $36K | Sell |
1,510
-6,300
| -81% | -$144K | ﹤0.01% | 3507 |
|
|
2016
Q1 | $183K | Buy |
7,810
+2,981
| +62% | +$70.8K | ﹤0.01% | 2383 |
|
|
2015
Q4 | $146K | Buy |
4,829
+3,467
| +255% | +$112K | ﹤0.01% | 2730 |
|
|
2015
Q3 | $54K | Buy |
+1,362
| New | +$84.5K | ﹤0.01% | 3480 |
|
|
2015
Q2 | – | Sell |
-483
| Closed | -$30.4K | – | 5333 |
|
|
2015
Q1 | $26K | Buy |
+483
| New | +$23K | ﹤0.01% | 3750 |
|
|
2014
Q4 | – | Sell |
-1,510
| Closed | -$54.6K | – | 5441 |
|
|
2014
Q3 | $48K | Buy |
1,510
+400
| +36% | +$8.53K | ﹤0.01% | 3553 |
|
|
2014
Q2 | $23K | Buy |
1,110
+584
| +111% | +$10.8K | ﹤0.01% | 4081 |
|
|
2014
Q1 | $10K | Buy |
+526
| New | +$11.2K | ﹤0.01% | 4590 |
|
Group One Trading's AMAG Position: Q1 2019 in Review
Group One Trading sold out of AMAG Pharmaceuticals (AMAG) in Q1 2019, closing a stake of 16,288 shares — an estimated $243K sold.
Group One Trading first reported a position in AMAG in Q1 2014 and held it in 14 quarters. The position peaked at $894K in Q1 2017. 166 funds tracked by Wall St. Rank hold AMAG as of Q1 2019.
- Group One Trading reported no remaining AMAG Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
- Group One Trading sold 16,288 AMAG Pharmaceuticals shares in Q1 2019, an estimated $243K.
- Group One Trading first reported a position in AMAG Pharmaceuticals in Q1 2014 and held it in 14 quarters.
- Group One Trading's AMAG Pharmaceuticals position peaked at $894K in Q1 2017.
- 166 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q1 2019.
Based on Group One Trading's 13F filing for Q1 2019, filed 13 May 2019.